STUDY DESIGN: This is a population-based retrospective cohort study using National Vital Statistics data. All women covered by Medicaid who delivered singleton gestations and had pregestational DM coded on the birth certificate in states using the 2003 birth certificate revision were included. We classified states as "expanded" if they implemented expansion programs in 2014. We compared maternal and neonatal outcomes in 2013 (before policy changes) and 2015 (1 year after Medicaid expansion was enacted) using a difference-indifferences approach to account for secular trends in outcomes unrelated to Medicaid expansion. We then constructed a multilevel model to investigate the association of Medicaid expansion with outcomes adjusted for age, race, education, parity, and clustering by state. RESULTS: Of 27,113 women who delivered during the study period, 12,795 (47.2%) were in states that expanded Medicaid. First trimester prenatal care entry was more common in 2015 than in 2013 in both expanded states (+4.6%) and non-expanded states (+3.4%), and was not associated with Medicaid expansion (adjusted odds ratio (aOR) 1.09, 95% CI 0.94-1.27). Primary cesarean delivery was less common in 2015 than in 2013 in both expanded (-0.8%) and non-expanded states (-0.9%), and these differences were not associated with Medicaid expansion (aOR 1.00, 95% CI 0.89-1.14). Although fewer infants were large-for-gestational age in 2015 than in 2013 in both expanded (-1.0%) and non-expanded states (-0.6%), frequency of neonatal morbidity (NICU admission at term, NICU admission overall, and >6 hours of respiratory support) increased over the study period; these changes were all independent of Medicaid expansion. (Table) CONCLUSION: Medicaid expansion was not associated with differences in early prenatal care, maternal or neonatal outcomes among women with pregestational DM. Access to preconception care is necessary, but insurance access alone may not be sufficient to improve outcomes in this population. OBJECTIVE: Current postpartum (PP) venous thromboembolism (VTE) prophylaxis (ppx) recommendations are based on consensus and expert opinion. PP VTE can result in morbidity and mortality, but it is a rare event. We compare the cost-effectiveness of three PP VTE ppx strategies in a general obstetric population. STUDY DESIGN: We constructed a decision analytic tree to model a population of women in the US under consideration for PP VTE ppx from a health care institution perspective. We considered three strategies: 1) mechanical ppx alone 2) RCOG risk-based protocol and 3) our local risk-based protocol (UAB). We assumed mechanical ppx would be used for all strategies and enoxaparin (LMWH) administered per strategy protocol (broad use for RCOG and narrow use for UAB). Patients with indications for therapeutic anticoagulation were excluded. Model inputs for probability and cost were derived from existing literature. Primary outcome was incremental cost per VTE/pulmonary embolus (PE) death prevented. Secondary outcomes included VTE, PE, death from bleeding attributable to heparin, wound hematoma and heparin-induced thrombocytopenia (HIT). A cost-benefit table was constructed using probabilistic estimates of outcomes and costs in a population of 100,000. One-and two-way sensitivity and probabilistic analyses were performed to explore parametric uncertainty. RESULTS: The incremental cost effectiveness of the UAB and RCOG protocols were $348,385 and $1,069,310 per VTE/PE death prevented, respectively. Mechanical ppx alone was less expensive and less effective than the UAB and RCOG protocols in preventing VTE, PE, and VTE/PE death, but resulted in fewer cases of wound hematoma and HIT (Table) . Incremental costs of UAB and RCOG protocols were considerable (Table) . In probabilistic analysis, mechanical ppx alone was cost-saving in 85% of 100,000 Monte Carlo simulations with the UAB protocol cost-saving in 15%. One-and two-way analyses showed that the UAB protocol is cost-saving if baseline VTE risk is >1.3%, VTE/PE death cost is >$544,457, PE cost is >$80,196, or LMWH cost is <$20.29. Regardless of LMWH cost, the RCOG protocol is never cost-saving ( Figure) . CONCLUSION: Risk-based PP VTE ppx protocols reduce the risk of VTE, PE, and VTE-related death, but are considerably costlier than mechanical ppx alone and result in more heparin-related adverse events.
Postpartum venous thromboembolism prophylaxis: A Cost-Effectiveness Analysis
OBJECTIVE: Current postpartum (PP) venous thromboembolism (VTE) prophylaxis (ppx) recommendations are based on consensus and expert opinion. PP VTE can result in morbidity and mortality, but it is a rare event. We compare the cost-effectiveness of three PP VTE ppx strategies in a general obstetric population. STUDY DESIGN: We constructed a decision analytic tree to model a population of women in the US under consideration for PP VTE ppx from a health care institution perspective. We considered three strategies: 1) mechanical ppx alone 2) RCOG risk-based protocol and 3) our local risk-based protocol (UAB). We assumed mechanical ppx would be used for all strategies and enoxaparin (LMWH) administered per strategy protocol (broad use for RCOG and narrow use for UAB). Patients with indications for therapeutic anticoagulation were excluded. Model inputs for probability and cost were derived from existing literature. Primary outcome was incremental cost per VTE/pulmonary embolus (PE) death prevented. Secondary outcomes included VTE, PE, death from bleeding attributable to heparin, wound hematoma and heparin-induced thrombocytopenia (HIT). A cost-benefit table was constructed using probabilistic estimates of outcomes and costs in a population of 100,000. One-and two-way sensitivity and probabilistic analyses were performed to explore parametric uncertainty. RESULTS: The incremental cost effectiveness of the UAB and RCOG protocols were $348,385 and $1,069,310 per VTE/PE death prevented, respectively. Mechanical ppx alone was less expensive and less effective than the UAB and RCOG protocols in preventing VTE, PE, and VTE/PE death, but resulted in fewer cases of wound hematoma and HIT (Table) . Incremental costs of UAB and RCOG protocols were considerable (Table) . In probabilistic analysis, mechanical ppx alone was cost-saving in 85% of 100,000 Monte Carlo simulations with the UAB protocol cost-saving in 15%. One-and two-way analyses showed that the UAB protocol is cost-saving if baseline VTE risk is >1.3%, VTE/PE death cost is >$544,457, PE cost is >$80,196, or LMWH cost is <$20.29. Regardless of LMWH cost, the RCOG protocol is never cost-saving ( Figure) . CONCLUSION: Risk-based PP VTE ppx protocols reduce the risk of VTE, PE, and VTE-related death, but are considerably costlier than mechanical ppx alone and result in more heparin-related adverse events.
OBJECTIVE:
The operative vaginal delivery (OVD) rate in the US has sharply declined e with the average OVDs performed by each graduating resident at our institution dropping from 82 in 2009 to just 22 in 2014. In response, our institution's OBGYN residency program implemented a yearly OVD curriculum (didactics + simulation twice yearly) in May 2016. We sought to evaluate the rate of total OVDs, forceps-(FAVD), and vacuum-assisted (VAVD) deliveries performed before and after the introduction of this OVD curriculum. STUDY DESIGN: We performed a retrospective cohort study of all deliveries at our institution from July 2011 -May 2018. Deliveries were evaluated quarterly for the pre-(July 2011-April 2016) and post-curriculum (July 2016-May 2018) time periods. FAVD, VAVD, total OVD rates and the ratio of forceps-to-vacuums were calculated for each time period. Pre-and post-curriculum rates were compared using Wilcoxon rank sum test. Cubic regression curves were fit to quarterly rates to illustrate trends over time. RESULTS: From July 2011-April 2016, our institution averaged 4154 AE 907 deliveries annually (68% spontaneous vaginal deliveries, 29% cesareans, and 3% OVDs. The OVD rate was unchanged following curriculum implementation (median 3.1% [2.6-3.5% IQR] Pre-vs 3.2% [2.5-3.8%] Post-, p>0.99). However, the FAVD rate was significantly increased (1.0% [0.8-1.5%] vs 2.2% [1.4-2.6%], p¼0.027) and the VAVD rate decreased (1.8% [1.6-2.2%] vs 1.1% [0.9-1.3%], p<0.001) between the pre-and post-curriculum groups. This was accompanied by a significant increase in the ratio of forceps-to-vacuum deliveries in the period post-curriculum (0.6 [0.4-0.8] vs 1.8 [1.3-2.2], p<0.001). These trends were demonstrated graphically in cubic regression curves fit to quarterly data over the study period e with FAVD rate higher in the last quarter than any other quarter in the 7 year study period (Figures 1 and 2) .
CONCLUSION:
The OVD rate at our institution has remained stable from July 2011 -May 2018; however, in the 2 years following the implementation of an OVD curriculum, the rate of FAVD and ratio of forceps-to-vacuum deliveries has significantly increased beyond values seen for the 5 years prior to this initiative. The implementation of an OVD curriculum in resident education increases the rate of FAVD performed.
744 Aspirin strategies for preeclampsia prevention: a cost-effectiveness analysis OBJECTIVE: To evaluate the cost-effectiveness of aspirin (ASA) prophylaxis guided by biomarker values and ultrasound indices for preeclampsia prevention compared to approaches based on clinical risk assessment. STUDY DESIGN: We designed a decision analysis model to compare the costs and effectiveness of four strategies to guide ASA use in pregnancy: (1) biomarkers and ultrasound risk assessment (2) the United States Preventive Services Task Force (USPSTF) risk factor based approach, (3) universal ASA, and (4) no ASA. In the base case
